Lindsay Eilers1, Athar M Qureshi2. 1. The Lillie Frank Abercrombie Section of Cardiology, Texas Children's Hospital, Baylor College of Medicine, 6651 Main Street, E 1920, Houston, TX, 77030, USA. 2. The Lillie Frank Abercrombie Section of Cardiology, Texas Children's Hospital, Baylor College of Medicine, 6651 Main Street, E 1920, Houston, TX, 77030, USA. axquresh@texaschildrens.org.
Abstract
PURPOSE OF REVIEW: To review the most recent literature on pediatric transcatheter ductal intervention including ductus arteriosus occlusion and stenting. RECENT FINDINGS: With the development and FDA approval of smaller ductal devices, including most recently the Amplatzer Piccolo Occluder (Abbott, Abbott Park, IL), transcatheter ductus arteriosus device closure is now being safely performed in premature infants and patients < 6 kg using a transvenous approach. In patients with ductus-dependent pulmonary blood flow, ductal stenting with pre-mounted coronary artery stents has been shown to be an acceptable alternative to the surgically placed Blalock-Taussig shunt. Centers with experience in ductal stenting have demonstrated success, even with the tortuous ductus. Innovation in transcatheter device technology and procedural practices have allowed for significant advances. Transcatheter ductal device closure is a reasonable alternative to surgical ligation even in premature, low-birthweight infants. Ductal stenting is also an accepted alternative to the modified Blalock-Taussig shunt. We anticipate continued advancement and procedural refinement over the next several years.
PURPOSE OF REVIEW: To review the most recent literature on pediatric transcatheter ductal intervention including ductus arteriosus occlusion and stenting. RECENT FINDINGS: With the development and FDA approval of smaller ductal devices, including most recently the Amplatzer Piccolo Occluder (Abbott, Abbott Park, IL), transcatheter ductus arteriosus device closure is now being safely performed in premature infants and patients < 6 kg using a transvenous approach. In patients with ductus-dependent pulmonary blood flow, ductal stenting with pre-mounted coronary artery stents has been shown to be an acceptable alternative to the surgically placed Blalock-Taussig shunt. Centers with experience in ductal stenting have demonstrated success, even with the tortuous ductus. Innovation in transcatheter device technology and procedural practices have allowed for significant advances. Transcatheter ductal device closure is a reasonable alternative to surgical ligation even in premature, low-birthweight infants. Ductal stenting is also an accepted alternative to the modified Blalock-Taussig shunt. We anticipate continued advancement and procedural refinement over the next several years.
Authors: Andrew C Glatz; Christopher J Petit; Bryan H Goldstein; Michael S Kelleman; Courtney E McCracken; Alicia McDonnell; Timothy Buckey; Christopher E Mascio; Subi Shashidharan; R Allen Ligon; Jingning Ao; Wendy Whiteside; W Jack Wallen; Christina M Metcalf; Varun Aggarwal; Hitesh Agrawal; Athar M Qureshi Journal: Circulation Date: 2017-10-17 Impact factor: 29.690
Authors: Ahmet Celebi; Ilker Kemal Yucel; Mustafa Orhan Bulut; Mehmet Kucuk; Sevket Balli Journal: Catheter Cardiovasc Interv Date: 2016-11-10 Impact factor: 2.692
Authors: Howaida G El-Said; Andras Bratincsak; Susan R Foerster; Joshua J Murphy; Julie Vincent; Ralf Holzer; Diego Porras; John Moore; Lisa Bergersen Journal: J Am Heart Assoc Date: 2013-11-27 Impact factor: 5.501
Authors: Abhay A Divekar; Yousef M Arar; Stephen Clark; Animesh Tandon; Thomas M Zellers; Surendranath R Veeram Reddy Journal: Children (Basel) Date: 2022-04-02